Bill
Bill > AJR92
NJ AJR92
NJ AJR92Designates May of each year as "Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Awareness Month."
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This resolution designates May of each year as "Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Awareness Month." Ehlers-Danlos Syndrome (EDS) represents multiple genetic disorders involving mutations in connective tissue that are characterized by looseness, instability, and dislocation of the joints and fragile skin that easily bruises and scars. There is currently no treatment for EDS and no known cure. Treatment for EDS focuses on managing symptoms and preventing complications through approaches like physical therapy, to improve joint stability, pain management strategies, and avoiding high-risk activities, and EDS support groups also help connect those managing life with the disease to available treatment services. Hypermobility spectrum disorders (HSD) are connective tissue disorders that cause joint hypermobility, instability, injury, and pain. Problems such as fatigue, headaches, gastrointestinal problems, and autonomic dysfunction are often seen as part of HSD. Both EDS and HSD involve joint hypermobility, chronic pain, fatigue, and sometimes autonomic or gastrointestinal symptoms. Ongoing medical research and growing awareness offer hope for improved treatments and, ultimately, a cure for EDS and HSD. In New Jersey, the Robert Wood Johnson University Hospital offers specialized care for individuals seeking diagnosis or management of EDS and HSD. May is recognized as Ehlers-Danlos Syndromes (EDS) and Hypermobility Spectrum Disorders (HSD) Awareness Month nationally, dedicated to raising awareness and support for those affected by these conditions. Officially designating May as "Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month" in New Jersey would help increase public understanding of these heritable connective tissue disorders and promote continued research aimed at improving diagnosis and treatment.
AI Summary
This joint resolution designates May of each year as "Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Awareness Month" to raise public understanding of these heritable connective tissue disorders, which are characterized by joint hypermobility, fragile skin, chronic pain, and fatigue, and to encourage ongoing research for better diagnosis and treatment. Ehlers-Danlos Syndrome (EDS) is a group of genetic disorders affecting connective tissue, while Hypermobility Spectrum Disorders (HSD) are related conditions causing symptomatic joint hypermobility and instability, often accompanied by other issues like fatigue and gastrointestinal problems. Although there is currently no cure for EDS and HSD, increased awareness and research offer hope for improved management and potential future cures, with specialized care available in New Jersey at Robert Wood Johnson University Hospital.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Introduced, Referred to Assembly Health Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/AJR92 |
| BillText | https://pub.njleg.gov/Bills/2026/AJR/92_I1.HTM |
Loading...